About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/22/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/22/2021.

Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities With Blood Flow Restriction

Clinicaltrials.gov identifier NCT03942510

Recruitment Status Active, not recruiting

First Posted May 8, 2019

Last update posted September 16, 2020

Study Description

Brief summary:

Introduction: Studies on resistance training (RT) associated with blood flow restriction (BFR) have emerged as an alternative method of gaining strength and hypertrophy; however, the cardiovascular and autonomic repercussion of BFR at different intensities is unknown. Thus, it becomes relevant to investigate this type of training in post-exercise. Objective: investigate and compare autonomic and hemodynamic responses of acute eccentric RT with different intensities associated or not to BFR in healthy youngsters. Method: This is a randomized clinical trial including 60 healthy men aged 18-35 years, divided into four groups according to exercise intensity and BFR: 80% without BFR, 40% without BFR, 80% with BFR and 40% with BFR. Exercise intensity will be determined by the peak of excentric torque on the dinamometer isokinetic method and by the BFR, as being 40% of the intensity required for the complete examination of the blood flow evaluated by Doppler. Participants will do an eccentric femoral quadriceps muscle exercise session on the isokinetic dynamometer according to the previously randomized group. For recovery analyzes, the recovery heart rate (HRR) in the 1st (HRR1) and 2nd (HRR2) minute, rMSSD of 30 seconds, the hemodynamic parameters (heart rate, systolic and diastolic blood pressure, respiratory rate, peripheral oxygen saturation and rate pressure product) and heart rate variability (HRV) indices analyzed in the time domain (mean HR, rMSSD and SDNN), frequency domain (LF and HF [nu and ms2]) and Poincaré plot (SD1 and SD2). The analysis will be occur on baseline, immediately e after the excentric exercise and in the post exercise period for 60 minutes. Descriptive statistics method and comparison of HRV indices and hemodynamic parameters between moments and groups will be performed with the aid of the analysis of variance technique for the repetitive measures model without the schema of two sets of tests to follow . The level of significance will be p <0.05.

  • Condition or Disease:Exercise
  • Intervention/Treatment: Other: eccentric exercise with blood flow restriction
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Interventional
  • Actual Enrollment: 60 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Investigator)
  • Primary Purpose: Other
  • Official Title: Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities Associated With Blood Flow Restriction: a Randomized Clinical Trial
  • Actual Study Start Date: March 2019
  • Estimated Primary Completion Date: October 2019
  • Actual Study Completion Date: December 2020
Arms and interventions
Arm Intervention/treatment
Experimental: High intensity eccentric training
high intensity (80% isometric peak) eccentric training of the knee extensors in the isokinetic will be performed during 6 weeks, 3 times a week.
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
Experimental: High intensity eccentric training with blood flow restriction
high intensity (80% isometric peak) eccentric training of the knee extensors in the isokinetic associated with a pressure cuff placed in the proximal thigh (40% of absolute occlusion pressure) will be performed during 6 weeks, 3 times a week.
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
Experimental: Low intensity eccentric training
A low intensity (40% isometric peak) eccentric training of the knee extensors in the isokinetic will be performed during 6 weeks, 3 times a week.
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
Experimental: Low intensity eccentric training with blood flow restriction
A low intensity (40% isometric peak) eccentric training of the knee extensors in the isokinetic associated with a pressure cuff placed in the proximal thigh (40% of absolute occlusion pressure)will be performed during 6 weeks, 3 times a week.
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
Outcome Measures
  • Primary Outcome Measures: 1. heart rate variability indices in the time domain [ Time Frame: Change from baseline at 3rd week and 6rd week ]
    mean HR, rMSSD and SDNN in ms
  • 2. heart rate variability indices analyzed in the Poincaré plot [ Time Frame: Change from baseline at 3rd week and 6rd week ]
    SD1 and SD2 in ms
  • 3. heart rate variability indices in the frequency domain [ Time Frame: Change from baseline at 3rd week and 6rd week ]
    LF and HF in nu and ms2
  • 4. vagal reentry [ Time Frame: Change from 1 day at 10 day and 18 day ]
    rMSSD of 30 seconds in ms
  • 5. heart rate recovery [ Time Frame: Change from 1 day at 10 day and 18 day ]
    the recovery heart rate (HRR) in the 1st (HRR1) and 2st (HRR2) minute [bpm]
  • Secondary Outcome Measures: 1. hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]
    heart rate [bpm]
  • 2. hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]
    systolic and diastolic blood pressure [mmHg]
  • 3. hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]
    respiratory rate [irpm]
  • 4. hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]
    peripheral oxygen saturation [%]
Eligibility Criteria
  • Ages Eligible for Study: 18 to 35 Years (Adult)
  • Sexes Eligible for Study: Male
  • Accepts Healthy Volunteers: Yes
Criteria

Inclusion Criteria:

- male sex;

- healthy;

- aged between 18 and 35 years

Exclusion Criteria:

- smokers;

- alcoholics;

- use drugs that influenced cardiac autonomic activity;

- cardiovascular, metabolic or endocrine diseases.

Contacts and Locations
Contacts
Locations

Brazil, SP
Leonardo Kesrouani Lemos
Presidente Prudente

Sponsors and Collaborators

Paulista University

Investigators

Principal Investigator: Franciele M Vanderlei, PhD Paulista State University

More Information
  • Responsible Party: Paulista University
  • ClinicalTrials.gov Identifier: NCT03942510 History of Changes
  • Other Study ID Numbers: U1111-1232-0808
  • First Posted: May 8, 2019 Key Record Dates
  • Last Update Posted: September 16, 2020
  • Last Verified: September 2020
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by Paulista University: resistance training
    vascular occlusion
    hemodynamics, cardiovascular system
    autonomic nervous system
    heart rate
    recovery of physiological function